The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
AACR has designated this live activity for a maximum of 28.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CLAIMING (CME) CREDIT
Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this live continuing medical education activity must complete the CME Request for Credit Survey, below, by Friday, November 30, 2012. Your CME certificate will be sent to you via email after the completion of the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES
Cost of cancer treatment in the United States has doubled since 1987. According to American Cancer Society, an estimated 1,638,910 new cancer cases are expected to be diagnosed in 2012. According to WHO, at least one-third of all cancer cases are preventable by successful behavioral interventions such as smoking cessation and increased physical activity. Cancer prevention not only saves lives but also eliminates the disease burden on health care system, thus offering the most cost-effective long-term strategy for the cancer control.
Along with behavioral changes, we should employ new technological advancements that can accurately help in risk assessment and early detection to intercept cancer in early stages. Thus, there is a great need to discuss novel approaches such as designing and execution of better chemoprevention trials, microbiome-associated therapeutic intervention, and biomarkers to accelerate prevention research. These new prevention strategies display the potential to have a major impact on cancer incidence throughout the world.
This conference will bring together over 500 scientists from basic researchers, physicians, clinician-scientists, and population scientists to discuss how advances across disciplines can be integrated to effectively prevent cancer. This will not only help in expanding their knowledge but also help in establishing new collaborations with other experts in the field of cancer prevention research.
After participating in this CME activity, physicians should be able to:
- Strategically design and execute new chemoprevention trials.
- Identify new advances in the field of biomarker discovery that will accelerate cancer prevention by better risk assessment, early detection, and intervention in individuals at risk of cancer, with ultimate goal of reducing cancer incidence globally.
- Analyze the results from sequencing of genome and translate this knowledge in providing state-of-the-art cancer screening procedures to at-risk individuals for better cancer prevention.
- Evaluate the role of microbiome (complex microbial communities living in/on human body) and how it helps in maintaining a healthy host-microbiota relationship to prevent susceptibility for cancer development.
- Articulate the unique challenges of achieving global cancer prevention.
- Determine how use of animal models can help in cancer prevention studies.
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Program/Proceedings of this conference.
ACKNOWLEDGMENT OF FINANCIAL OR OTHER SUPPORT
This activity is supported by grants and will be disclosed at the activity.
QUESTIONS ABOUT CME?
Please contact the Office of CME at (215) 440-9300 or email@example.com.